
Aequs Share Price Hits All-Time High, Up 11% in Two Days as Nuvama Sees Up to 91% Upside
Aequs share price up 7.23% at Rs 259.95 on 8 Jul 2026, all-time high, up 11% in 2 days. Nuvama initiates buy, target Rs 444, up to 91% upside. Order book USD 889 million.
Updated: 8 Jul 2026 • 12:45 pm
Posted by:

Aequs share price extended its rise to hit a fresh all-time high on Wednesday, 8 July 2026, up about 11 percent over two sessions, after brokerage Nuvama Institutional Equities initiated coverage on the stock with a buy rating and a 12 month target price of Rs 444, implying an upside of up to 91 percent from the previous close.
Aequs emerged as the top gainer in the Nifty India Defence index for the second consecutive session, with the stock rising 7.23 percent to Rs 259.95 on the day, building on the previous session’s over 5 percent gain that followed Nuvama’s initiation.
Click Here – Get Free Investment Predictions
Aequs Share Price Today: Nuvama Coverage Details
| Metric | Value |
|---|---|
| Stock | Aequs |
| CMP (8 July 2026) | Rs 259.95 |
| Day Change | +7.23 percent |
| 2 Day Gain | About 11 percent |
| Nuvama Rating | Buy (initiated) |
| Nuvama Target Price | Rs 444, implying up to 91 percent upside |
| Order Book | USD 889 million |
| CY2026 YTD Return (before today) | Over 75 percent |
Get Defence and Aerospace Stock Guidance from a SEBI Registered Investment Advisor at Univest
Why Nuvama Is Bullish on the Aequs Share Price
Nuvama’s bull case centres on Aequs being India’s only vertically integrated aerospace special economic zone, supplying machined aerostructures, landing gear and engine parts to global original equipment manufacturers such as Airbus and Boeing. The brokerage called Aequs India’s first genuine pure play aerospace precision manufacturer, describing its position as a moat built over time rather than through capital alone.
The brokerage highlighted Aequs’ USD 889 million order book as supporting a projected 42 percent sales CAGR and 84 percent EBITDA CAGR over FY26 to FY28, and argued the stock deserves a valuation premium over pharma contract manufacturers since, unlike drug molecules, aircraft programmes do not expire.
What Should Investors Watch in the Aequs Share Price
Investors tracking the Aequs share price should watch execution against the large order book, progress on planned capital expenditure of USD 350 to 450 million, and OEM production rate trends at Airbus and Boeing. Nuvama flagged supply chain disruptions, dependence on Chinese technology, customer concentration and OEM production rate volatility as the key risks to monitor.
Download the Univest iOS App or Univest Android App to track the Aequs share price live and get more Aequs share price research.
Conclusion
Aequs share price hit a fresh all-time high, rising 7.23 percent to Rs 259.95 on 8 July 2026, after Nuvama initiated coverage with a buy rating and a Rs 444 target implying up to 91 percent upside. The stock has gained about 11 percent over two sessions. Investors should track order execution and consult a SEBI registered advisor before investing.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions FAQs
What is Nuvama’s target price for Aequs?
Ans. Nuvama Institutional Equities has set a 12 month target price of Rs 444 for Aequs, implying an upside of up to 91 percent from the stock’s previous close, with a buy rating.
What is the Aequs share price today?
Ans. Aequs share price rose 7.23 percent to Rs 259.95 on 8 July 2026, hitting a fresh all-time high and extending its two day gain to about 11 percent.
Why is Nuvama bullish on Aequs?
Ans. Nuvama is bullish because Aequs is India’s only vertically integrated aerospace SEZ supplying to global OEMs like Airbus and Boeing, with a USD 889 million order book supporting strong projected sales and EBITDA growth.
What is Aequs’ order book?
Ans. Aequs has a USD 889 million order book, which Nuvama says supports a projected 42 percent sales CAGR and 84 percent EBITDA CAGR over FY26 to FY28.
What are the key risks to the Aequs investment case?
Ans. Nuvama flagged supply chain disruptions, raw material and Chinese technology dependence, customer concentration, execution risk in the consumer segment, and OEM production rate volatility as key risks.
Should investors buy Aequs shares after the all-time high?
Ans. A brokerage upgrade with a large target price is not a guarantee of returns, especially after a sharp rally. Investors should review the order book execution and valuation, and consult a SEBI registered investment advisor before investing.
Where can investors track the Aequs share price live?
Ans. Investors can track the Aequs share price live on the NSE and BSE websites, as well as on broker and research platforms covering the stock through the trading session.
Recent Articles

Gulshan Polyols Q1 Results FY27: Date, Revenue Estimates, Key Catalysts and Share Price Target
8 July 2026

Aqylon Nexus Q1 Results FY27: Date, Revenue Estimates, Key Catalysts and Share Price Target
8 July 2026

DEN Networks Q1 Results FY27: Date, Revenue Estimates, Key Catalysts and Share Price Target
8 July 2026

Meghmani Organics Q1 Results FY27: Date, Revenue Estimates, Key Catalysts and Share Price Target
8 July 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
Gulshan Polyols Q1 Results FY27: Date, Revenue Estimates, Key Catalysts and Share Price Target
Aqylon Nexus Q1 Results FY27: Date, Revenue Estimates, Key Catalysts and Share Price Target
DEN Networks Q1 Results FY27: Date, Revenue Estimates, Key Catalysts and Share Price Target
Meghmani Organics Q1 Results FY27: Date, Revenue Estimates, Key Catalysts and Share Price Target
Salasar Techno Engineering Q1 Results FY27: Date, Revenue Estimates, Key Catalysts and Share Price Target
Popular this week
Gulshan Polyols Q1 Results FY27: Date, Revenue Estimates, Key Catalysts and Share Price Target
Aqylon Nexus Q1 Results FY27: Date, Revenue Estimates, Key Catalysts and Share Price Target
DEN Networks Q1 Results FY27: Date, Revenue Estimates, Key Catalysts and Share Price Target
Meghmani Organics Q1 Results FY27: Date, Revenue Estimates, Key Catalysts and Share Price Target
Salasar Techno Engineering Q1 Results FY27: Date, Revenue Estimates, Key Catalysts and Share Price Target

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times





